XIAP and acute myeloid leukemia: Since overexpression of the X-linked inhibitor of apoptosis protein (XIAP) in AML might confer chemoresistance, molecules that downregulates XIAP were thought to be useful for the treatment of patients with high levels of this antiapoptotic protein.